Friday, August 12, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models

by Medical Finance
in News
Manipulating voltage patterns in tumor cells reduces breast cancer metastasis in animal models
10
SHARES
106
VIEWS
Share on FacebookShare on Twitter

In normal cells, electrical voltage patterns provide a blueprint for orderly growth. But with cancer, the opposite happens. Marked by a breakdown in the normal electrical patterns generated by the cells, they lose their specialized functions, start expanding into a tumor and spreading into and disrupting the function of other tissues -; metastasis. As of yet, there are no clinically available treatments that specifically target the process of metastasis, which remains the leading cause of death in cancer patients.

Now researchers at Tufts University have found that manipulating voltage patterns in tumor cells using ion channel blockers already FDA-approved as treatments for other diseases can in fact significantly reduce tumor cell invasion in a dish and metastasis in an animal model of breast cancer.

The discovery, published in eBioMedicine, showed that drugs already approved for other conditions can slow or stop metastasis could lead to an expedited path to approval for the treatment of cancer.

This is very much an unexplored, but highly opportunistic strategy for the treatment of cancer. Ion channels, which regulate the bioelectrical properties of cells, are the second-most common target for existing pharmaceuticals, so we have a relatively large set of ready-to-use drugs that could be repurposed for cancer therapy.”


Madeleine Oudin, Tiampo Family Assistant Professor of biomedical engineering at Tufts University School of Engineering and corresponding author of the study

To test their therapeutic strategy, the Tufts research team focused on triple-negative breast cancer (TNBC), a subtype of the disease which accounts for approximately 15% of all breast cancer cases. The likelihood of metastasis for TNBC is greater than all other subtypes of breast cancer, and because TNBC is associated with a poor five-year prognosis, scientists are focusing efforts on counteracting it.

The researchers were able to show that manipulating the voltage properties of breast cancer cells can have a significant effect on their progression to metastasis, reducing the number of metastatic sites in mouse lungs by about 50%.

Cells in the body create a natural voltage across their membranes, caused by ion channels that actively push or passively allow positive and negative ions into and out of the cell. Mike Levin, Vannevar Bush Professor in the Department Biology, a collaborator on this study, has been working on dissecting the role of electrical properties in cellular behaviors for many years in model organisms. When Oudin joined Tufts, they received funding through the Tufts Collaborates program, which helps support collaborations between faculty in different schools to tackle new exciting areas of research.

While there are a variety of channels that drive the movement of positively charged sodium, calcium, and potassium ions, as well as negatively charged chloride ions, potassium ion channels tend to dominate in generating the voltage across the cell membrane. When the Tufts researchers genetically over-expressed the potassium ion channels in tumor cells, the inside of the cells became more negatively charged, and the imbalance in voltage led to increased tumor growth and metastasis, both in plated cells and animal models.

The researchers’ therapeutic strategy took the opposite approach-;blocking the potassium ion channels led to a restoration of more normal voltages for the cells, decreased tumor cell invasion and significantly reducing metastasis.

Four FDA-approved potassium ion channel blockers were screened, and all had similar effectiveness in killing tumors cells. One drug, amiodarone, had the largest effect on normalizing cell voltages and was selected to see how well it would work in treating breast cancer in mice. The researchers found that the drug, approved for use treating heart rhythm disorders, cut back on the tumors’ ability to spread as cells broke off and move to other parts of the body.

By looking at the genes that were triggered by the voltage shift, they found a number of molecular pathways involved in the movement of cells. The effects of the ion channel blocking drug were consistent with limiting the cells movement, so they don’t wander off and grow new tumors.

The Tufts team will continue to explore the effects of the ion channel blockers on cancer in animal models, in combination with existing standard of care treatments like chemotherapy. Since amiodarone and similar drugs are already approved for use in humans, phase I clinical trials in small groups of cancer patients could commence in the near future.

Source:

Journal reference:

Payne, S.L., et al. (2021) Potassium channel-driven bioelectric signalling regulates metastasis in triple-negative breast cancer. eBioMedicine. doi.org/10.1016/j.ebiom.2021.103767.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Rapid DNA sequencing technique used to diagnose rare genetic disease in short time

Mount Sinai and Regeneron Genetics Center launch a new human genome sequencing research project

by Medical Finance
August 12, 2022
0

Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing...

Study: Nano-vectors for CRISPR/Cas9-mediated genome editing. Image Credit: Meletios Verras/Shutterstock

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

by Medical Finance
August 12, 2022
0

In a recent study published in the journal Nano Today, researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced...

Research provides a comprehensive map of exercise-induced signaling molecules present in the tissues

Research provides a comprehensive map of exercise-induced signaling molecules present in the tissues

by Medical Finance
August 12, 2022
0

It is well established that exercise improves health, and recent research has shown that exercise benefits the body in different...

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

Study identifies cellular receptors for alphaviruses shared across mosquitoes, humans, and animals

by Medical Finance
August 12, 2022
0

A new study led by researchers at Harvard Medical School has identified a set of cellular receptors for at least...

Grouping tumors by ‘immune archetypes’ points the way to personalized immunotherapies

Researchers engineer enucleated cells to deliver therapeutics precisely to diseased tissues

by Medical Finance
August 12, 2022
0

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health report...

First patient-derived stem cell model developed for studying oculocutaneous albinism

Pathogens turn off mitochondrial defense by hijacking a normal cellular response to stress

by Medical Finance
August 12, 2022
0

Mitochondria are known as energy suppliers for our cells, but they also play an important role in the defense against...

Next Post
Study: COPD and social distancing in the UK. Image Credit: Stock-Asso/Shutterstock

COPD patients more compliant with COVID-19 restrictions in the UK

Study: CCBYNC Open access Research Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. Image Credit: Yuganov Konstantin/Shutterstock

Hazards of persistent and new clinical sequelae caused by SARS-CoV-2 infection among elderly patients

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • HEALTHCARE shutterstock 493063267 99928a5e003043f896998f01b025b9f6 620x480
    Immune-boosting supplements do not lessen risk of death from COVID-19, review finds
  • Staphylococcus aureus 620x480
    Spex CertiPrep® adds Staphylococcus aureus and Salmonella pathogen detection kits to its portfolio
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply